Freenome Freenome Launches Multi-Cancer Detection Study Using Multiomics, Real-World Evidence The company plans to analyze both traditional and real-world data from about 8,000 individuals to validate and optimize its multi-cancer early detection platform. People in the News at Freenome, Quadrant Biosciences, Igentify, More People in the News: New Appointments at Freenome, Natera, Mission Bio, More Freenome Nets $290M Investment From Roche The company said the latest influx brings its total funding to more than $1 billion and will help the firm expand its cancer detection platform to multiple tumor types. Freenome Raises $300M in Series D Financing The company will use the funding to support commercialization of its blood-based colorectal cancer detection test and to fuel expansion to other tumor types. Dec 1, 2021 Freenome, Siemens Healthineers Partner to ID Blood-Based Breast Cancer Biomarkers Sep 30, 2021 Pancreatic Cancer Data Preview Freenome's Plans for Expanded Cancer Detection Assay Premium Aug 28, 2020 Freenome Maintains CRC Early Detection Timeline as New Biomarker Discovery Studies Progress Premium Aug 26, 2020 Freenome Closes $270M Series C Financing to Support Early Cancer Detection Trial May 29, 2020 People in the News: John Henderson, Daniel Spiegelman, Eric Schaefer, More May 28, 2020 Freenome Begins Prospective Study of Noninvasive Colorectal Cancer Screening Test Premium Feb 5, 2020 Methylation, Fragmentation Analyses Remain at Forefront of Early Detection Liquid Biopsy Development Premium Aug 29, 2019 Freenome Expands Into Biomarker Discovery While Maintaining Early Detection Goals Premium Aug 26, 2019 Freenome, ADC Therapeutics Sign Biomarker Development Deal Jul 24, 2019 Freenome Closes $160M Series B Financing Round Apr 1, 2019 Guardant Health AACR Data Hint at Future Potential of Bellwether Acquisition Premium Oct 9, 2018 Freenome Shares New cfDNA Data, Building Evidence for Colorectal Cancer Blood Test Premium Jun 28, 2018 Freenome, Medical University of Graz Partner on Cancer Biomarker Research Breaking News Liver Cancers Detected With Parallel Mutation, Methylation Liquid Biopsy Approach In Brief This Week: Biocept, Thermo Fisher, Biodesix, More Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test Lucira Health Molecular COVID/Flu Test Gets FDA Emergency Use Authorization Biocare Medical Acquires Empire Genomics The Scan UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways. Survey Sees Genetic Literacy on the Rise, Though Further Education Needed Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds. Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers. FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.